Literature DB >> 9634524

Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria.

R Kruse1, A Rütten, C Lamberti, H R Hosseiny-Malayeri, Y Wang, C Ruelfs, M Jungck, M Mathiak, T Ruzicka, W Hartschuh, M Bisceglia, W Friedl, P Propping.   

Abstract

Muir-Torre syndrome (MTS) is an autosomal dominant disease defined by the coincidence of at least one sebaceous skin tumor and one internal malignancy. About half of MTS patients are affected by colorectal cancer. In a subgroup of MTS patients the disease has an underlying DNA mismatch-repair (MMR) defect and thus is allelic to hereditary nonpolyposis colorectal cancer (HNPCC). The purpose of this study was to examine to what extent germ-line mutations in DNA MMR genes are the underlying cause of the MTS phenotype. We ascertained 16 MTS patients with sebaceous skin tumors and colorectal cancer, and we examined their skin and visceral tumors for microsatellite instability. All the patients exhibited high genomic instability in at least one tumor. The search for germ-line mutations in the hMSH2 and hMLH1 genes in 13 of the MTS patients revealed truncating mutations in 9 (69%): eight mutations in the hMSH2 gene and one in the hMLH1 gene. This is the first systematic search for germ-line mutations in patients ascertained on the basis of sebaceous skin tumors. Our results indicate that (1) MTS patients exhibit significantly more mutations in the hMSH2 gene than in the hMLH1 gene; and (2) the subpopulation of MTS patients who are also affected by colorectal cancer, irrespective of family history and age at onset of tumors, may have a likelihood for an underlying DNA MMR defect similar to that for patients with a family history fulfilling the strict clinical criteria for HNPCC.

Entities:  

Mesh:

Year:  1998        PMID: 9634524      PMCID: PMC1377247          DOI: 10.1086/301926

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

2.  Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer.

Authors:  M Miyaki; M Konishi; K Tanaka; R Kikuchi-Yanoshita; M Muraoka; M Yasuno; T Igari; M Koike; M Chiba; T Mori
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Muir-Torre syndrome. Histologic spectrum of sebaceous proliferations.

Authors:  W H Burgdorf; J Pitha; A Fahmy
Journal:  Am J Dermatopathol       Date:  1986-06       Impact factor: 1.533

5.  Single-step screening method for the most common mutations in familial adenomatous polyposis.

Authors:  W Friedl; M Mandl; M Sengteller
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

Review 6.  Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.

Authors:  P R Cohen; S R Kohn; R Kurzrock
Journal:  Am J Med       Date:  1991-05       Impact factor: 4.965

Review 7.  Obstructive jejunal adenocarcinoma in the Muir-Torre syndrome.

Authors:  S C Panday; I H Go; M Mravunac; R W de Koning
Journal:  Neth J Med       Date:  1993-10       Impact factor: 1.422

8.  Microsatellite instability in Muir-Torre syndrome.

Authors:  R Honchel; K C Halling; D J Schaid; M Pittelkow; S N Thibodeau
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

9.  The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome.

Authors:  H T Lynch; P M Lynch; J Pester; R M Fusaro
Journal:  Arch Intern Med       Date:  1981-04

Review 10.  Muir-Torre syndrome: a case report.

Authors:  M Bisceglia; P Zenarola
Journal:  Tumori       Date:  1991-06-30
View more
  31 in total

Review 1.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.

Authors:  Angela Arnold; Stewart Payne; Samantha Fisher; Diane Fricker; Judith Soloway; Susan M White; Marco Novelli; Kylie MacDonald; James Mackay; Richard Groves; Natalie Canham
Journal:  Fam Cancer       Date:  2007-02-24       Impact factor: 2.375

Review 3.  Prophylactic surgery in Lynch syndrome.

Authors:  V Celentano; G Luglio; G Antonelli; R Tarquini; L Bucci
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

4.  [Recurrent eyelid tumors with different dignities].

Authors:  U Löw; C S L Müller; E Zemova; F A Flockerzi; B Seitz
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

5.  Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?

Authors:  Alessandro Vaisfeld; Martina Calicchia; Maria Grazia Pomponi; Emanuela Lucci-Cordisco; Luca Reggiani-Bonetti; Maurizio Genuardi
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

Review 6.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

7.  FANCJ localization by mismatch repair is vital to maintain genomic integrity after UV irradiation.

Authors:  Shawna Guillemette; Amy Branagan; Min Peng; Aashana Dhruva; Orlando D Schärer; Sharon B Cantor
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

Review 8.  Genetics of skin appendage neoplasms and related syndromes.

Authors:  D A Lee; M E Grossman; P Schneiderman; J T Celebi
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

9.  [Muir-Torre syndrome with previously undescribed frameshift mutation in the MSH2 gene].

Authors:  B Gilly; A Unholzer; G Strobl-Wildemann; C Haas; H Starz; J Welzel
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

Review 10.  10 rare tumors that warrant a genetics referral.

Authors:  Kimberly C Banks; Jessica J Moline; Monica L Marvin; Anna C Newlin; Kristen J Vogel
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.